Skip to content

To define the optimal glucose intake in critically ill children

To define the optimal glucose intake in critically ill children - define optimal glucose intake critically ill children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35471
Enrollment
64
Registered
2009-01-08
Start date
2009-11-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ernstig zieke kinderen met verschillende aandoeningen nvt

Interventions

One group will first get the lower amount of glucose infusion followed by the higher amount. The other group will first get the higher amount of glucose infusion followed by the lower amount. They a

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: -critically ill patients after elective surgery ( cardial, craniofacial of scoliosis surgery) admitted to the ICU -critically ill patients with various medical diseases and > 1 organ failure admitted to the ICU. - with arterial line -inclusion 1 to 12 hours after admission -cardiorespiratory stable -only parental glucose after admission

Exclusion criteria

Exclusion criteria: endocrine disorders, liver failure, chromosomal disorders, insulin therapy no arterial line of after removal arterial line no informed consent in case of patient after elective cardiac surgery: no extracorporal circulation during cardiac surgery

Design outcomes

Primary

MeasureTime frame
-endogenous glucose production -fractional gluconeogenesis -glucose utilization -whole body protein balance. - fractional albumin synthesis rate.

Secondary

MeasureTime frame
indirect calorimetry:determination of total energy expenditure urine samples for nitrogen excretion: protein utilization anthropometry

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)